切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 301 -304. doi: 10.3877/cma.j.issn.2095-3224.2017.04.007

所属专题: 文献

论著

结直肠癌原发肿瘤部位对术后患者生存的影响
刘静1, 李文雅1, 曲秀娟1, 曲晶磊1, 陈颖1, 赵婉聿1, 李智1, 刘云鹏1,()   
  1. 1. 110001 沈阳,中国医科大学附属第一医院肿瘤内科
  • 收稿日期:2017-04-16 出版日期:2017-08-25
  • 通信作者: 刘云鹏
  • 基金资助:
    辽宁省科学技术计划项目(No.2014226033,2014225013); 辽宁省中央引导地方科技发展专项资金(No.2016007010)

Association of primary tumor location with prognosis in postoperative colorectal cancer patients

Jing Liu1, Wenya Li1, Xiujuan Qu1, Jinglei Qu1, Ying Chen1, Wanyu Zhao1, Zhi Li1, Yunpeng Liu1,()   

  1. 1. Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, China
  • Received:2017-04-16 Published:2017-08-25
  • Corresponding author: Yunpeng Liu
  • About author:
    Corresponding author: Liu Yunpeng, Email:
引用本文:

刘静, 李文雅, 曲秀娟, 曲晶磊, 陈颖, 赵婉聿, 李智, 刘云鹏. 结直肠癌原发肿瘤部位对术后患者生存的影响[J]. 中华结直肠疾病电子杂志, 2017, 06(04): 301-304.

Jing Liu, Wenya Li, Xiujuan Qu, Jinglei Qu, Ying Chen, Wanyu Zhao, Zhi Li, Yunpeng Liu. Association of primary tumor location with prognosis in postoperative colorectal cancer patients[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(04): 301-304.

目的

探讨大肠癌原发肿瘤部位与临床病理特征的关系,以及原发肿瘤部位对生存的影响。

方法

纳入2000年9月至2016年4月就诊于中国医科大学附属第一医院肿瘤内科的I~III期根治性切除术后大肠癌患者,分析大肠癌原发肿瘤部位与临床病理特征的关系,以及对预后的影响。

结果

1 345例大肠癌患者根据原发肿瘤部位不同,分为直肠、左半结肠、右半结肠3组。结果显示,原发肿瘤部位与性别(χ2=10.943;P=0.004)、组织学分级(χ2=12.402;P=0.015)、病理T分期(χ2=49.794;P<0.001)、TNM分期(χ2=30.102;P<0.001)显著相关。生存分析结果显示,3组间的生存时间差异未见明显统计学意义(χ2=4.806;P=0.09)。单因素分析发现,原发肿瘤位置与预后未见显著相关性(χ2=2.938;P=0.088),而淋巴结转移数目(χ2=39.739)及TNM分期(χ2=23.872)与预后显著相关,P值均<0.001;多因素分析结果显示,仅淋巴结转移数目与预后显著相关(95%CI:1.210~2.317;P=0.002)。

结论

根治性切除术后结直肠癌的原发肿瘤部位不同,其临床病理特征有所不同。原发肿瘤部位与预后未见显著相关性,仅淋巴结转移数目可作为独立预后因素。

Objective

To investigate the association of primary tumor location with clinical pathologic features and prognosis in postoperative colorectal cancer patients.

Methods

Patients with stage I~III colorectal cancer treated in the First Hospital of China Medical University from September 2000 to April 2016 were collected, and the relationship between primary tumor location and clinical pathological features was analyzed. The effect of primary tumor location on the prognosis was also investigated.

Results

In total, 1 345 patients with colorectal cancer were grouped according to primary tumor location: the rectum, left-sided, and right-sided colon group. The primary tumor location was associated with gender ( (χ2=10.943; P=0.004), histological grade (χ2=12.402; P=0.015), pathological T stage (χ2=49.794; P<0.001) and TNM stage (χ2=30.102; P<0.001) . Survival analysis showed no significant difference in three groups (χ2=4.806; P=0.09). Cox univariate analysis did not show any correlation between primary tumor location and survival (χ2=2.938; P=0.088) , but showed a significant correlation between positive lymph nodes、TNM stage and prognosis (χ2=39.739, χ2=23.872; P<0.001). Multivariable analyses showed a significant correlation between positive lymph nodes and survival (95%CI: 1.210~2.317; P=0.002).

Conclusion

In postoperative colorectal cancer, different primary tumor location correlated with different clinical pathological characteristics. There was no relationship between primary tumor location and prognosis. Number of positive lymph nodes was an independent prognostic factor for survival.

表1 原发肿瘤部位与临床病理特征的关系(例,%)
表2 结直肠癌临床病理特征与预后的单因素及多因素分析
图1 原发肿瘤部位与OS关系
[1]
Jemal A, Bray F, Center MM, et al.Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
[2]
Center MM, Jemal A, Ward E.International trends in colorectal cancer incidence rates[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(6):1688-1694.
[3]
Bufill JA.Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location[J]. Ann Intern Med, 1990, 113(10):779-788.
[4]
Brule SY, Jonker DJ, Karapetis CS, et al.Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17[J]. European Journal of Cancer, 2015, 51(11):1405-1414.
[5]
Iacopetta B.Are there two sides to colorectal cancer?[J]. Int J Cancer, 2002, 101(5):403-408.
[6]
Jess P, Hansen IO, Gamborg M, et al.A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer[J]. BMJ Open, 2013, 3(5):pii:e002608.
[7]
Ishihara S, Nishikawa T, Tanaka T, et al.Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study[J]. Int J Surg, 2014, 12(9):925-930.
[8]
Benedix F, Meyer F, Kube R, et al. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma[J]. Pathol Res Pract, 2012 , 208(10):592-597.
[9]
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[J]. N Engl J Med, 2004, 350(23):2335–2342.
[10]
Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer - a systematic review[J]. Danish Medical Journal, 2012, 59(6):A4444.
[11]
Clark S.Outcome of right - and left-sided colonic and rectal cancer following surgical resection[J]. Colorectal Dis, 2012, 14(3):386.
[12]
Christodoulidis G, Spyridakis M, Symeonidis D, et al.Clinicopathological differences between right - and left-sided colonic tumors and impact upon survival[J]. Techniques in coloproctology, 2010, 14(Suppl 1):S45-47.
[13]
Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right - and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival[J]. Dis Colon Rectum, 2010 , 53(1):57-64.
[14]
Cassidy J, Clarke S, Díaz-Rubio E, et al. XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results[J]. Br J Cancer, 2011, 105(1):58–64.
[15]
Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study[J]. J Clin Oncol, 2008,26(12):2013–2019.
[16]
Moritani K, Hasegawa H, Okabayashi K, et al. Difference in the recurrence rate between right - and left - sided colon cancer: a 17-year experience at a single institution[J]. Surgery today, 2014, 44(9):1685-1691.
[17]
Huang CW, Tsai HL, Huang MY, et al. Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer[J]. World J Surg Oncol, 2015, 13:257.
[18]
Nitsche U, Stögbauer F, Späth C, et al. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis[J]. Digestive Surgery, 2016, 33(2):157-163.
[19]
von Einem JC, Heinemann V, von Weikersthal LF, et al.Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial[J]. J Cancer Res Clin Oncol, 2014, 140(9):1607-1614.
[20]
He WZ, Xia LP. RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer[J]. J Natl Cancer Inst, 2015, 107(9).
[21]
Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right - versus left-sided colon cancers?[J]. Ann Surg Oncol, 2008, 15(9):2388-2394.
[22]
Weiss JM, Pfau PR, O'Connor ES, et al.Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data[J]. J Clin Oncol, 2011, 29(33):4401-4409.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 581-587.
[2] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[3] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[4] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[8] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[9] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[10] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[11] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[12] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要